| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| R&D Expense | $0.8B | $0.5B | $0.3B | $0.2B | $0.1B | $0.0B |
| SG&A Expense | — | — | — | — | — | — |
| Operating Income | $-0.9B | $-0.6B | $-0.5B | $-0.2B | $-0.1B | $-0.0B |
| Net Income | $-0.8B | $-0.5B | $-0.4B | $-0.2B | $-0.1B | $-0.0B |
| EPS (Basic) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | — | — |
| EPS (Diluted) | $-5.63 | $-3.80 | $-4.14 | $-3.44 | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Total Assets | $3.0B | $3.5B | $1.4B | $1.0B | $0.3B | $0.4B |
| Current Assets | $1.6B | $1.8B | $1.1B | $0.9B | $0.3B | $0.4B |
| Cash & Equivalents | $0.2B | $0.4B | $0.4B | $0.8B | $0.1B | $0.4B |
| Total Liabilities | $0.3B | $0.2B | $0.2B | $0.1B | $0.0B | $0.0B |
| Current Liabilities | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Stockholders' Equity | $2.7B | $3.3B | $1.2B | $1.0B | $0.3B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $-0.7B | $-0.5B | $-0.3B | $-0.2B | $-0.1B | $-0.0B |
| Investing Cash Flow | $0.4B | $-2.0B | $-0.8B | $0.1B | $-0.2B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.0B | $2.4B | $0.6B | $0.9B | $0.0B | $0.4B |